Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Current Medical Research and Opinion|February 10, 2006
Clinical experience and management considerations with long-acting risperidoneEduard Parellada
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 21, 2026
MicroRNAs as potential biomarkers in schizophrenia: Current methodological limitations and challengesMar Hernaez, Eduard Parellada, Mercè Brunet
The Journal of Clinical Psychiatry|April 21, 2004
Risperidone in the treatment of patients with deliriumEduard Parellada, Inmaculada Baeza, Joan de Pablo, et al.
International Clinical Psychopharmacology|March 23, 2010
Safety and efficacy of long-acting injectable risperidone in daily practice: an open-label, noninterventional, prospective study in schizophrenia and related disordersEduard Parellada, Filippos Kouniakis, Aldona Siurkute, et al.
International Journal of Psychiatry in Clinical Practice|November 23, 2017
An open-treatment six-week study of the clinical effectiveness of Paliperidone Palmitate in schizophrenia: data from acute units in Spain (SHADOW study)Eduard Parellada, Miquel Bioque, Manuel Serrano, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 1, 2011
Neurotoxic/neuroprotective activity of haloperidol, risperidone and paliperidone in neuroblastoma cellsPatricia Gassó, Sergi Mas, Oriol Molina, et al.
Medicina Clinica|December 20, 2008
[Effect of polymorphisms of the cathecol-O-methyltransferase on schizophrenia risk in a Spanish population]Sergi Mas, Patricia Gassó, Anna Crescenti, et al.
Pageof 7